Floatz logo

128 assets in Stroke Disorder

Therapeutic assets addressing Stroke Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Atenolol
Stroke Disorder
Northern California Institute of Research and EducationP4BBB (75)
Tenecteplase
Stroke Disorder
Assistance Publique - Hôpitaux de ParisP4BBB (73)
Rivaroxaban
Stroke Disorder
China National Center for Cardiovascular DiseasesP4BBB (72)
Aspirin
Stroke Disorder
China National Center for Cardiovascular DiseasesP4BB (71)
Atorvastatin
Stroke Disorder
Duan ChuanzhiP4BB (71)
Clopidogrel
Stroke Disorder
Shanghai CureGene Pharmaceutical Co., Ltd.P4BB (71)
Ticagrelor
Stroke Disorder
Assistance Publique - Hôpitaux de ParisP4BB (71)
Tirofiban
Stroke Disorder
Weifang Medical UniversityP4BB (71)
Warfarin
Stroke Disorder
China National Center for Cardiovascular DiseasesP4BB (71)
Alteplase
Stroke Disorder
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP4BB (70)
Cilostazol
Stroke Disorder
Northern California Institute of Research and EducationP4BB (70)
Edoxaban
Stroke Disorder
Ewha Womans University Seoul HospitalP4BB (70)
Xeomin®
Stroke Disorder
Universiteit AntwerpenP4BB (70)
Labetalol
Stroke Disorder
ProMedica Health SystemP3BB (69)
Elavolocumab
Stroke Disorder
The Affiliated Hospital of Xuzhou Medical UniversityP4BB (68)
Ivolumab
Stroke Disorder
The Affiliated Hospital of Xuzhou Medical UniversityP4BB (68)
Lidocaine
Stroke Disorder
Institut National de la Santé Et de la Recherche Médicale, FranceP4BB (67)
Propofol
Stroke Disorder
Johns Hopkins UniversityP4BB (67)
Simvastatin
Stroke Disorder
Northern California Institute of Research and EducationP4BB (67)
Sovateltide
Stroke Disorder
Pharmazz, Inc.P3BB (67)
Cerebrolysin
Stroke Disorder
Cardinal Stefan Wyszynski UniversityP4BB (66)
Compound Edaravone
Stroke Disorder
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP4BB (66)
Dabigatran
Stroke Disorder
Brigham and Women's HospitalP4BB (66)
Dipyridamole
Stroke Disorder
The Second Hospital of Anhui Medical UniversityP4BB (66)
Apixaban
Stroke Disorder
Columbia UniversityP4BB (65)
Botulinum B Toxin
Stroke Disorder
Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLCP4BB (65)
Metamizole
Stroke Disorder
Region Örebro CountyP4BB (65)
Rosuvastatin
Stroke Disorder
Assiut UniversityP4BB (65)
Hydroxyurea
Stroke Disorder
Vanderbilt University Medical CenterP4BB (64)
Levodopa
Stroke Disorder
University Hospital, Basel, SwitzerlandP4BB (64)
Hydrochlorothiazide
Stroke Disorder
Northern California Institute of Research and EducationP4B (63)
Minocycline
Stroke Disorder
Joyce ChenP4B (63)
Apsolol
Stroke Disorder
Beijing Tiantan HospitalP3B (62)
Carbidopa
Stroke Disorder
University Hospital, Basel, SwitzerlandP4B (62)
Folic Acid
Stroke Disorder
Beijing Tiantan HospitalP4B (62)
Hypoxanthine Riboside
Stroke Disorder
POLYSAN Scientific & Technological Pharmaceutical CompanyP3B (62)
Lacto-Flavin
Stroke Disorder
POLYSAN Scientific & Technological Pharmaceutical CompanyP3B (62)
Multiple Vitamins Injection
Stroke Disorder
POLYSAN Scientific & Technological Pharmaceutical CompanyP3B (62)
Recombinant Human Tissue Kallikrein
Stroke Disorder
DiaMedica Therapeutics IncP2/3B (62)
Escitalopram
Stroke Disorder
Johns Hopkins UniversityP4B (61)
mlc1501
Stroke Disorder
Moleac Pte Ltd.P2/3B (61)
Amlodipine
Stroke Disorder
Beijing Tiantan HospitalP4B (60)
Asundexian
Stroke Disorder
BayerP3B (60)
Citalopram
Stroke Disorder
Chih-Wei TangP4B (60)
Semaglutide
Stroke Disorder
University of WashingtonP4B (60)
Spt-07A
Stroke Disorder
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP3B (60)
Tocilizumab
Stroke Disorder
Zhujiang HospitalP3B (60)
Tizanidine
Stroke Disorder
Northwestern UniversityP3B (59)
Ezetimibe
Stroke Disorder
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP4B (58)
Telmisartan
Stroke Disorder
Spaulding Rehabilitation HospitalP4B (58)
Showing 1 to 50 of 128 assets
PreviousPage 1 of 3Next